Skip Navigation

University at Buffalo - The State University of New York
  1. Home
  2. About
    1. FAQ
    2. Staff
    3. Contact Us
    4. Who We Are
  3. Campus Info
    1. History of UB
    2. Building Profiles
    3. Campus Maps
    4. Floor Plans
  4. Projects
    1. 2010 Project Maps
    2. Project Gallery
    3. FP&D Project Archive
  5. Requests
    1. Small Scale Capital Request Form
    2. Large Scale Capital Request Form
    3. Space Request Form
    4. Exterior Signage Request Form
    5. UB on the Move

Home > Departments > Facilities Planning & Design > Campus Info > Building Profiles > South Campus Building Profiles > Kapoor (John) Hall

Kapoor (John) Hall

Kapoor (John) Hall

Facility:
Number:
Function:
Gross Square Feet:
Construction Cost:
Completed:
Architect:

OCCUPANTS 

Kapoor (John) Hall Occupany Report  Adobe Reader Document (PDF)

FUNCTION 

The approximately 160,000 square foot facility, recently renamed in honor of alumnus John Kapoor ‘72, will be home to The School of Pharmacy and Pharmaceutical Sciences to be relocated from Cooke-Hochstetter Hall on North Campus. Demolition has begun and is expected to be complete in late Spring 2009. The existing building will be stripped down to its original concrete structural frame and.will incorporate many green design features such as maximizing natural daylight (75 percent of all space in the building will receive natural light). The building will achieve a LEED silver rating. The building will provide a state-of-the-art Pharmaceutical Care and Teaching Center and establish a better link between the Academic Health Center and the School of Pharmacy and Pharmaceutical Sciences. Construction Completion is scheduled for end of 2011 with occupancy and classes occuring summer 2012.

NAMESAKE 

John Kapoor, Ph.D.President of EJ Financial Enterprises, Inc., and a skilled entrepreneur who has transformed numerous businesses into profitable corporations, John N. Kapoor, Ph.D. '72, for nearly a decade has been the most generous donor to the UB pharmacy school, which is ranked in the top two of Northeast U.S. pharmacy schools and in the top 25 nationwide.  Born in Amristar, India, Kapoor earned an undergraduate degree in pharmacy from Bombay University, and sought to attend graduate school in the United States. UB offered him a graduate fellowship, allowing him to pursue a doctorate in medicinal chemistry.  Throughout his career, Kapoor has demonstrated keen marketing insight. As president and CEO of LyphoMed, he rejuvenated the hospital products company into a more than $100-million-a-year business, which he then sold to Fujisawa Pharmaceuticals. He went on to serve in leadership positions at several U.S. pharmaceutical companies over the next 30 years, including Option Care, Inc., a provider of home health-care services; Akorn, Inc., a manufacturer and marketer of generic ophthalmic products; and Introgen Therapeutics, Inc., a gene therapy company.